Chiara Pierantoni

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

Mario Scartozzi, Silvia Chiorrini, Riccardo Giampieri et al. · Annals of Oncology · 2008 · 324 citations

Hypertension, Surgical Oncology, Oncology +10

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

Stefano Cascinu, Rossana Berardi, Roberto Labianca et al. · The Lancet Oncology · 2008 · 132 citations

Pancreatic Cancer, Phase Ii Trial, Gastrointestinal Oncology +6

Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

Mario Scartozzi, Italo Bearzi, Chiara Pierantoni et al. · Journal of Clinical Oncology · 2007 · 126 citations · Full text

Role of maspin in cancer

Rossana Berardi, Francesca Morgese, Azzurra Onofri et al. · Clinical and Translational Medicine · 2013 · 109 citations · Full text

Oncology, Medicine, Cancer Growth +12

Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours

Gianluca Spitaleri, Rossana Berardi, Chiara Pierantoni et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 100 citations · Full text

Cancer Immunosurveillance, Oncology, Phase I/ii Study +10